Fenwick represented Perceive Bio on the deal.Perceive Bio, a biotech company pioneering novel technologies and therapeutics in ophthalmology, announced its $78 million Series B financing. The round…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
